You have 9 free searches left this month | for more free features.

MSI-H/dMMR Gastric Cancer (1)

MSI-H/dMMR Gastroesophageal-junction Cancer (1)

Not yet recruiting (1)

phase 1/phase 2 (1)

Servier Bio-Innovation LLC (1)

Institut de Recherches Internationales Servier (1)

Merck Sharp & Dohme LLC (1)

pembrolizumab 200 mg (1)

s095029 (1)

drug (1)

Industry (1)

Interventional (1)

s095029

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Oct 30, 2023